Paulo Cesar Maciag
1. Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization.Mustafa W, Maciag PC, Pan ZK, ...Weaver JR, Xiao Y, Isaacs SN, Paterson Y
Viral Immunol. 2009 Jun. 22(3): 195-204
2. The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix.
Maciag PC, Radulovic S, Rothman J
Vaccine. 2009 Jun 19. 27(30): 3975-83
3. An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.
Seavey MM, Maciag PC, Al-Rawi N, ...Sewell D, Paterson Y
J Immunol. 2009 May 1. 182(9): 5537-46
4. Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.
Wallecha A, Carroll KD, Maciag PC, ...Rivera S, Shahabi V, Paterson Y
Adv Appl Microbiol. 2009. 66: 1-27
5. A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors.
Seavey MM, Pan ZK, Maciag PC, ...Wallecha A, Rivera S, Paterson Y, Shahabi V
Clin Cancer Res. 2009 Feb 1. 15(3): 924-32
6. Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy.
Wallecha A, Maciag PC, Rivera S, ...Paterson Y, Shahabi V
Clin Vaccine Immunol. 2009 Jan. 16(1): 96-103
7. Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases.
Kim SH, Castro F, Gonzalez D, ...Maciag PC, Paterson Y, Gravekamp C
Br J Cancer. 2008 Sep 2. 99(5): 741-9
8. Listeria-based vaccines for cancer treatment.
Paterson Y, Maciag PC
Curr Opin Mol Ther. 2005 Oct. 7(5): 454-60
9. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication.
Boyer JD, Robinson TM, Maciag PC, ...Peng X, Johnson RS, Pavlakis G, Lewis MG, Shen A, Siliciano R, Brown CR, Weiner DB, Paterson Y
Virology. 2005 Mar 1. 333(1): 88-101
Pages:
1
